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Abstract: The role of the macrophage in influenza virus infection is complex.  Macrophages are
critical for resolution of influenza virus infections but implicated in morbidity and
mortality in severe infections.  They can be infected with influenza virus and
consequently macrophage infection is likely to have an impact on the host immune
response.  Macrophages display a range of functional phenotypes from the prototypical
pro-inflammatory classically activated cell to alternatively activated anti-inflammatory
macrophages involved in immune regulation and wound healing.  We were interested
in how macrophages of different phenotype respond to influenza virus infection and
therefore have studied the infection of bone marrow derived macrophages (BMDMs) of
classical and alternative phenotype in vitro.  Our results show that alternatively
activated macrophages are more readily infected and killed by the virus than classically
activated.  Classically activated BMDMs express the proinflammatory markers
inducible nitric oxide synthase (iNOS) and TNFα and TNFα expression was further up-
regulated following infection.  Alternatively activated macrophages express Arginase-1
and CD206, however, following infection, expression of these markers is down
regulated while expression of iNOS and TNFα is upregulated.  Thus, infection can
override the anti-inflammatory state of alternatively activated macrophages.
Importantly, however, this results in lower levels of pro-inflammatory markers than
those produced by classically activated cells.  Our results show that macrophage
phenotype affects the inflammatory macrophage response following infection and
indicate that modulating the macrophage phenotype may provide a route to develop
novel strategies to prevent and treat influenza virus infection.
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Summary 22 
The role of the macrophage in influenza virus infection is complex.  Macrophages are critical 23 
for resolution of influenza virus infections but implicated in morbidity and mortality in severe 24 
infections.  They can be infected with influenza virus and consequently macrophage infection 25 
is likely to have an impact on the host immune response.  Macrophages display a range of 26 
functional phenotypes from the prototypical pro-inflammatory classically activated cell to 27 
alternatively activated anti-inflammatory macrophages involved in immune regulation and 28 
wound healing.  We were interested in how macrophages of different phenotype respond to 29 
influenza virus infection and therefore have studied the infection of bone marrow derived 30 
macrophages (BMDMs) of classical and alternative phenotype in vitro.  Our results show that 31 
alternatively activated macrophages are more readily infected and killed by the virus than 32 
classically activated.  Classically activated BMDMs express the proinflammatory markers 33 
inducible nitric oxide synthase (iNOS) and TNFα and TNF expression was further up-34 
regulated following infection.  Alternatively activated macrophages express Arginase-1 and 35 
CD206, however, following infection, expression of these markers is down regulated while 36 
expression of iNOS and TNFα is upregulated.  Thus, infection can override the anti-37 
inflammatory state of alternatively activated macrophages. Importantly, however, this results 38 
in lower levels of pro-inflammatory markers than those produced by classically activated cells.  39 
Our results show that macrophage phenotype affects the inflammatory macrophage response 40 
following infection and indicate that modulating the macrophage phenotype may provide a 41 
route to develop novel strategies to prevent and treat influenza virus infection. 42 
 43 
44 
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Introduction 45 
Influenza A viruses impose a considerable burden on human health.  Seasonal influenza virus 46 
infections range from mild to life-threatening with the outcome dependent on both strain of 47 
virus and host response.  They are associated with significant morbidity and mortality, 48 
particularly in the elderly and the very young.  The emergence of highly pathogenic avian 49 
strains that can infect humans, albeit with a limited ability to spread human to human, presents 50 
an additional threat (Webster & Govorkova, 2014).  A key feature of these strains is an 51 
overreactive immune response that fails to control the infection, resulting in excessive 52 
production of cytokines and chemokines, influx of immune cells and severe immunopathology 53 
which contributes to high mortality (Cheung et al., 2002; Kobasa et al., 2007; Korteweg & Gu, 54 
2008).  55 
 56 
Influenza virus primarily infects epithelial cells in the respiratory track but also has a well-57 
recognized ability to infect macrophages (Rodgers & Mims, 1982; Tumpey et al., 2005). 58 
Macrophages play a central role in initiating and controlling the immune response to infections 59 
and infection of these innate immune cells is highly likely to have consequences for the 60 
outcome of infection.  It is clear, however, that the ability to infect and replicate in macrophages 61 
is dependent on both virus strain and origin of the macrophage and that the results of infection 62 
are highly variable (Nicol & Dutia, 2014; Short et al., 2012).  Infection of monocyte derived 63 
macrophages in vitro with highly pathogenic viruses leads to production of higher levels of 64 
inflammatory cytokines and chemokines than are produced in response to infection with low 65 
pathogenicity seasonal viruses (Cheung et al., 2002; Zhou et al., 2006) suggesting that 66 
infection of macrophages may be, at least in part, responsible for the increased pathogenicity 67 
of these viruses.  In vivo studies, however, have shown that a virus strain that readily infects 68 
macrophages in vitro is less pathogenic in mice than a related virus that fails to infect 69 
macrophages (Tate et al., 2010). In this instance, depletion of macrophages increases the 70 
virulence suggesting that macrophage infection can attenuate pathogenesis.   71 
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Macrophages are not, however, a single homogeneous population.  They are highly 72 
pleiomorphic cells with a range of phenotypes and functions (Gordon & Taylor, 2005).  At the 73 
extremes of the spectrum of macrophage phenotypes are the “classically activated” or M1 74 
macrophage, generally considered to be pro-inflammatory, producing TNFα, IL-6, IL-1β and 75 
inducible nitric oxide synthase (iNOS), while the “alternatively activated” or M2 macrophage 76 
has up-regulated expression of the macrophage mannose receptor CD206 and MHC class II, 77 
produces high levels of Arginase-1 (Arg-1) and endocytic function and is considered to be 78 
associated with wound healing and repair.  IFN and TNFα drive classical macrophage 79 
activation while alternative macrophage activation is driven by the Th2 cytokines IL-4 and IL-80 
13.  Between these two extremes lies a range of subtly different phenotypes which orchestrate 81 
and regulate the immune response (Gordon, 2003).  82 
 83 
We hypothesized that susceptibility and subsequent response of macrophages to influenza 84 
virus infection may depend on their phenotype, and that it would be possible to alter the extent 85 
of infection and thus influenza-associated pathology by manipulating macrophage phenotype.  86 
Here we show that alternatively activated BMDMs are more susceptible to infection with the 87 
A/WSN/33 strain of influenza virus than classically activated BMDMs and are more readily 88 
killed by infection.  Infection of alternatively activated BMDMs overrides their anti-inflammatory 89 
state, inducing a pro-inflammatory macrophage phenotype.  However, infection of alternatively 90 
activated BMDMs results in production of lower levels of pro-inflammatory markers including 91 
iNOS and TNFα than infection of classically activated BMDMs.  Overall, our study supports 92 
the hypothesis that alternatively activated macrophages have a protective role in highly 93 
pathogenic virus infection. 94 
  95 
96 
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Results 97 
129Sv/Ev bone marrow derived macrophages can be infected with influenza virus strain 98 
A/WSN/33 99 
Previous studies have reported that influenza viruses can infect macrophages with varying 100 
efficiency in a virus strain dependent manner (Reading et al., 2000; Rodgers & Mims, 1981; 101 
Tate et al., 2010).  We wished to investigate the ability of A/WSN/33 to infect macrophages 102 
from mice on the 129Sv/Ev background, therefore we derived macrophages from femurs of 6-103 
8 week old female 129Sv/Ev mice by culture for 7 days in medium containing M-CSF.  FACS 104 
analysis showed that >95% of the cells expressed the macrophage markers CD11b and F4/80 105 
(data not shown) and therefore were of macrophage phenotype (Misharin et al., 2013).  The 106 
bone marrow derived macrophages (BMDMs) were infected with varying multiplicities of 107 
infection (MOI) using viral titres determined on MDCK cells, incubated for various lengths of 108 
time and stained for viral antigen using a polyclonal antibody directed against purified H1N1 109 
virus. No antigen positive cells were detected at 1h post-infection (Fig1b) but positive cells 110 
were detected from 6h post-infection (fig 1c,d) indicating that viral protein synthesis was 111 
required for antibody staining.  An MOI of 10 resulted in infection of around 60% of cells but 112 
increasing the amount of input virus did not increase the percentage of cells infected further.  113 
Poisson distribution predicts that, if BMDMs were as infected with the same efficiency as 114 
MDCKs, an MOI of 5 should result in infection rate of > 99% of cells.  Thus, although BMDM 115 
can be infected with A/WSN/33, they are less readily infected than MDCK cells. 116 
 117 
Effect of macrophage phenotype on infection  118 
In order to produce polarized macrophage populations, we treated macrophages derived from 119 
wild type 129Sv/Ev mice and mice on the same genetic background lacking the IFN receptor 120 
(IFNR-/-) with IFN or IL-4 for 16 hours and measured levels of iNOS and Arg-1 by qRT-PCR 121 
and biochemical assay.  Figure 2 shows that treatment of both 129Sv/Ev and IFNR-/- BMDMs 122 
with IL-4 (Fig 2a,b) for 16 hours led to induction of Arg-1 mRNA and arginase activity, indicating 123 
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that the macrophages had differentiated to an alternatively activated –like phenotype.  124 
Treatment of 129Sv/Ev BMDMs with IFN resulted in production of iNOS mRNA and iNOS 125 
activity (Fig 2c,d) confirming that these BMDMs had differentiated to a classical phenotype.  126 
IFNR-/- BMDM cannot respond to IFN and therefore were not able to produce a classical 127 
macrophage response, ie they did not upregulate iNOS upon IFN treatment (Fig 2c,d).  We 128 
next infected the polarized macrophages with A/WSN/33 and stained with antibody to H1N1 129 
virus (Fig 3).  Treatment of 129Sv/Ev and IFNR-/- BMDMs with IFN or IL-4 and infection with 130 
virus did not affect the cell density (Fig 3a-c, f-h).  However, it was clear from 6hr post-infection 131 
that IL-4 treated macrophages were more readily infected than IFN treated macrophages (Fig 132 
3d & i).  Similar results were observed at 48h post-infection (Fig 3e & j) and intervening time 133 
points.   Thus, alternatively activated macrophages from both strains of mice are more readily 134 
infected than classically activated.   135 
 136 
Consistent with the higher levels of viral antigen present in alternatively activated 137 
macrophages, qRT-PCR showed significantly higher amounts of M1 mRNA synthesized in 138 
these cells indicating higher levels of viral infection (p<0.001) (Fig 4). 139 
 140 
Survival of influenza virus infected macrophages 141 
The survival of influenza virus infected BMDMs was assessed by use of the CellTiter-Blue 142 
viability assay.   Figures 5 a & b show that by 20h post-infection, infection of alternatively 143 
activated macrophages resulted in a significantly lower rate of viability than seen in infected 144 
classically activated macrophages. Interestingly, 129Sv/Ev IFN treated macrophages show a 145 
trend towards higher viability than untreated BMDMs from the same mice (Fig 5a).  This 146 
difference is not apparent for the IFNR-/- BMDMS which cannot respond to IFN suggesting 147 
that classical activation confers protection against virus induced cell death.    These data 148 
suggest that IL-4 activation renders BMDM more permissive for A/WSN/33 and that once 149 
infected, these cells are more readily killed by the virus than classically activated cells.  In order 150 
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to determine whether higher levels of productive virus infection occurred in alternatively 151 
activated macrophages, we measured the infectious virus present in the cell supernatants (Fig 152 
5c).  At 48h post-infection, the amount of virus in supernatants was higher than at 1h post-153 
infection indicating that there was a low level replication in the BMDMs.  However, the amount 154 
of virus recovered was less than the amount of input virus and we found no evidence that 155 
alternative activation resulted in production of higher levels of infectious virus by the BMDMs.  156 
 157 
Cytokine response to influenza virus infection 158 
In order to assess the effect of influenza virus infection on macrophage phenotype, we 159 
analysed the expression of phenotypic markers in infected/polarized BMDMs.  iNOS, TNFα 160 
and IL-12p40 were chosen as markers of classically activated macrophages.  iNOS is 161 
associated with inflammatory macrophage response and the secreted cytokines TNFα and IL-162 
12p40 contribute to macrophage driven inflammatory response.  In addition to Arg-1, which is 163 
highly expressed in alternatively activated macrophages (Fig 2), we measured expression of 164 
the mannose receptor, CD206 which is upregulated on alternatively activated macrophages 165 
(Gordon, 2003).  BMDMs were treated with IFN or IL-4 and infected with A/WSN/33 at an MOI 166 
of 10.  Cells were harvested at 48 hours post-infection and the expression of markers was 167 
measured by qRT-PCR.  Treatment of 129Sv/Ev macrophages with IFN upregulated iNOS 168 
by >104 fold and no further upregulation was induced by infection with virus (Fig 6a).  Similar 169 
results were found for IL-12p40 (data not shown).  In contrast, TNFα expression in these 170 
macrophages, although elevated by IFN alone, was significantly higher in cells which had 171 
been infected with virus (p<0.05, Fig 6e).  Thus virus infection can drive expression of this pro-172 
inflammatory cytokine.  Arg-1 and CD206 expression in the IFN treated 129Sv/Ev 173 
macrophages was low and virus infection did not alter this (Fig 6c,g).  As expected, IFN 174 
treatment of macrophages grown from IFNR-/- mice did not result in significant changes in 175 
expression of the classical markers iNOS and TNFα (Fig 6a,e). Infection of IFNR-/- 176 
macrophages with influenza virus upregulated iNOS expression (Fig 6a) indicating the virus 177 
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alone could switch on expression of this inflammatory marker.  TNFα expression was clearly 178 
completely dependent on the IFN activity as there was no change in expression following 179 
virus infection of the IFNR-/- macrophages (Fig 6e). Similarly, there was no significant change 180 
in IL-12p40 expression (data not shown).  Thus, infection of classically activated macrophages 181 
leads to increased expression of TNFα enhancing the pro-inflammatory state of these 182 
macrophages.  In the absence of IFN responsiveness infection led to enhanced expression 183 
of iNOS but did not induce synthesis of secreted pro-inflammatory cytokines (TNFα and IL-12) 184 
indicating that these macrophages did not enter a pro-inflammatory state.   185 
 186 
Alternative activation of BMDMs from both wild type 129Sv/Ev and IFNR-/- mice resulted in 187 
upregulation of Arg-1 and CD206 compared to untreated BMDMs (Fig 6d,h).  Classical markers 188 
were low or undetectable in these cells (Fig 6b,f).  However, infection of alternatively activated 189 
129Sv/Ev BMDMs induced expression of iNOS and TNFα indicating that virus infection could 190 
override the alternative, anti-inflammatory state of these macrophages, produce a pro-191 
inflammatory state within the cells (iNOS) and led to secretion of pro-inflammatory cytokines 192 
(Fig 6b,f).  Similarly, iNOS was significantly upregulated following infection of alternatively 193 
activated IFNR-/- BMDMs (Fig 6b; p<0.001) but levels were lower than those produced in 194 
alternatively activated 129Sv/Ev BMDMs.  Again, expression of TNFα was completely 195 
dependent on responsiveness to IFN (Fig 6f).  Infection of alternatively activated wild type 196 
129Sv/Ev and IFNR-/- BMDMs led to decreased expression of Arg-1 and CD206 (Fig 6 d,h).  197 
Thus, infection of alternatively activated macrophages led to down regulation of alternative 198 
markers and induction of the pro-inflammatory mediators iNOS and TNFα.  However, the levels 199 
of these cytokines produced by alternatively activated macrophages are less than those 200 
produced by classically activated macrophages.  Whilst infection can clearly override the anti-201 
inflammatory state, infection of alternatively activated macrophages leads to lower levels of 202 
pro-inflammatory cytokine production than those observed following infection of classically 203 
activated macrophages.   204 
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Discussion 205 
Our results show that alternatively activated macrophages are more susceptible to infection 206 
with A/WSN/33 than classically activated cells.  A higher percentage of cells express viral 207 
antigens and higher levels of M1 mRNA are produced in alternatively activated cells than in 208 
classically activated cells.  Similarly, Hoeve et al (Hoeve et al., 2012) showed that following 209 
infection with the H3N2 virus Udorn, a significantly higher number of human monocyte derived 210 
macrophages with anti-inflammatory characteristics contained viral antigen than those with 211 
proinflammatory phenotype.  The effect of IL-4 on uptake of antigens by macrophages is 212 
dependent on both antigen and pathway.  Treatment of macrophages with IL-4 leads to 213 
increased uptake of soluble antigen as well as increased mannose receptor dependent uptake 214 
of antigen (Montaner et al., 1999; Raveh et al., 1998).  However, alternative activation of 215 
macrophages with IL-4 has been shown to impair phagocytosis of bacteria and microbial 216 
particles (Varin et al., 2010).  The higher levels of M1 mRNA in IL-4 treated cells argue that 217 
the presence of virus antigen in cells is not simply due to increased phagocytosis of viral 218 
antigens but rather is due to increased infection of these macrophages. Influenza viruses 219 
usually enter cells by endocytosis following initial binding of the HA to sialic acids on the cell 220 
surface (Matlin et al., 1981; Skehel & Wiley, 2000).  However, there is evidence that influenza 221 
A virus can use other cell surface molecules including the macrophage mannose receptor 222 
CD206, macrophage galectin type lectins DC-SGN and L-SIGN to bind to and enter 223 
macrophages (Londrigan et al.; Reading et al., 2000; Upham et al., 2010).  Alternatively 224 
activated macrophages express a different range of cell surface proteins to those found on 225 
classically activated macrophages.  For example, CD206, is more highly expressed on the 226 
surface of alternatively activated macrophages than on classically activated and is indeed 227 
considered a marker for alternative activation (Gordon, 2003; Stein et al., 1992).  At this point, 228 
further work is required to understand the mechanisms by which alternatively activated 229 
macrophages are more readily infected but this may have important implications for influenza 230 
virus pathogenesis.  231 
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Interestingly, alternatively activated macrophages are more readily killed by infection with 232 
A/WSN/33 than classically activated macrophages. Influenza virus infection leads to cell death 233 
hence it is likely that the difference reflects the level of infection.  qRT-PCR data show that at 234 
48h post-infection there is up to 100 fold more M1 mRNA in alternatively activated cultures 235 
than in classically activated.  This, together with the fact that a higher percentage of 236 
alternatively activated macrophages is infected is consistent with the higher level of cell death 237 
found in alternatively activated cultures.  It is notable, however, that the apparently more 238 
permissive state of alternatively activated macrophages did not lead to production of higher 239 
levels of  infectious virus than are found in classically activated cells.  Although there is 240 
evidence for productive influenza virus infections in human macrophages (Hoeve et al., 2012; 241 
Perrone et al., 2008; van Riel et al., 2011; Yu et al., 2011), a number of publications have 242 
reported that influenza virus infection is abortive in murine macrophages (Rodgers & Mims, 243 
1981; Tate et al., 2011; Tate et al., 2010).  Our data show that whilst there is some replication 244 
of A/WSN/33 in murine BMDMs  the ability to produce infectious virus is not related to the 245 
activation state of the macrophage.  The ease with which alternatively activated macrophages 246 
become infected has important implications, i.e. manipulation of phenotype in vivo may allow 247 
macrophages to act as a sink for virus.  248 
 249 
Infection of both classically and alternatively activated 129Sv/Ev macrophages resulted in up-250 
regulation of TNFα, a cytokine associated with severe influenza virus infections in vivo.  251 
Macrophages can produce IFN (Gessani & Belardelli, 1998; Schroder et al., 2004) and 252 
therefore it is likely that autocrine production of this cytokine contributes to the ability of 253 
alternatively activated macrophages to override the IL-4 response and produce an 254 
inflammatory response.  Infection also resulted in upregulation of iNOS and IL12p40 in 255 
alternatively activated 129Sv/Ev macrophages.  Type I interferons and IL-1β can induce 256 
synthesis of iNOS (Gao et al., 1998; Geller et al., 1995) and it is likely these cytokines together 257 
with TNFα and IFN are involved in induction of iNOS and IL-12p40 following virus infection 258 
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(Drapier et al., 1988; Farrell & Blake, 1996; Ma et al., 1996).  The upregulation of 259 
proinflammatory markers together with the down regulation of Arg-1 and CD206 expression 260 
demonstrates that infection results in a switch in cell phenotype.  However, although both 261 
classes of macrophage produced a pro-inflammatory response following virus infection, 262 
alternatively activated macrophages produced lower levels of proinflammatory markers than 263 
classically activated macrophages.  Thus, the data support the hypothesis that manipulation 264 
of the macrophage phenotype could have an impact on influenza virus pathogenesis.   265 
 266 
IFNR-/- macrophages were significantly compromised in pro-inflammatory responses and 267 
TNFα production was severely limited.  Influenza virus infection did induce iNOS and IL-12p40 268 
in these macrophages, most likely due to the action of type I interferons and IL-1β, but levels 269 
were 1000 fold less than in wild type classically activated infected macrophages.  Non-270 
activated IFNR-/- BMDMs have significantly higher expression of CD206 than 129Sv/Ev 271 
BMDMs.  Given that CD206 has been shown to act as a receptor for influenza virus, it is 272 
interesting to speculate that this may play a role in the increased susceptibility to infection 273 
found in these macrophages.  Overall, these data provide evidence IFN responsiveness is 274 
critical to the macrophage response to influenza virus infection and highlight the role of IFN 275 
as a critical cytokine in pathogenesis of influenza virus infections.   276 
 277 
We have chosen to investigate the infection of BMDM and have successfully demonstrated 278 
that alternatively activated macrophages and those which cannot effectively mount a classical 279 
response (IFNR-/-) are more susceptible to influenza virus infection.  Whilst these studies were 280 
carried out with BMDMs rather than alveolar macrophages, they provide important clues for 281 
understanding the function of macrophages in control of influenza virus infections.  Recently it 282 
has been shown that alternatively activated alveolar macrophages can protect against lethal 283 
challenge in a mouse model (Wang et al., 2013).  That study did not address macrophage 284 
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infection but our data would suggest that infection of alternatively activated macrophages per 285 
se is likely to play a role in this protective effect.  286 
 287 
Macrophages clearly play a critical role in influenza virus infection.  Depletion of macrophages 288 
in animal models leads to exacerbation of infection indicating their importance in an effective 289 
host response to infection (Tate et al., 2011; Tumpey et al., 2005).  Similarly, transfer of 290 
macrophages accounts for the protective effect of prior infection with a herpesvirus (Saito et 291 
al., 2013).  However, they are major producers of inflammatory cytokines and hence have been 292 
implicated in the development of the severe pathology associated with fatal infections (Cheung 293 
et al., 2002; Perrone et al., 2008).  Our study shows that macrophages of different phenotypes 294 
respond very differently to influenza virus infection.  Given the diversity and plasticity of 295 
macrophages, understanding the interaction between macrophage phenotype and virus 296 
infection is likely to be fundamental to the development of novel strategies to prevent and treat 297 
severe influenza virus infections.  298 
299 
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Methods 300 
Cell culture 301 
L929 murine fibroblasts were grown in tissue culture flasks (Nunc) in Rosewell Park Memorial 302 
Institute Medium (RPMI) supplemented with 10% foetal calf serum, 100units/ml penicillin, 303 
100g/ml streptomycin and 2mM L-glutamine (Invitrogen).  Supernatant from confluent 304 
cultures was pooled, clarified by centrifugation at 8000g and stored in aliquots at -20oC as a 305 
source of M-CSF for bone marrow derived macrophages (BMDM). 306 
 307 
Madin Darby canine kidney cells (MDCKs) were grown in Dulbecco’s Modified Eagles Medium 308 
(DMEM, Invitrogen) supplemented as for RPMI.   309 
 310 
Virus growth and assay 311 
A/WSN/33 was propagated on MDCKs at a multiplicity of infection (MOI) of 0.001 for 48 hours 312 
before harvest of supernatant containing the virus.  Supernatant was clarified by centrifugation 313 
at 3000g and stored in aliquots at -80°C.  Titre was determined by plaque assay as previously 314 
described (Nicol et al., 2012). 315 
 316 
Macrophage isolation, activation and infection 317 
129Sv/Ev and IFNR-/- mice on the 129Sv/Ev background (Huang et al., 1993) were purchased 318 
from B & K Universal and bred in-house.  Femurs from 6-8 week old female mice were 319 
removed, cleaned in alcohol and the bone marrow flushed out with supplemented RPMI, using 320 
a 25G needle and syringe.  Bone marrow cells were plated onto 100mm bacteriological dishes 321 
(Sterilin) in 50% supplemented RPMI: 50% L929 fibroblast conditioned media (complete 322 
macrophage media).  Cultures were initially set up by seeding cells from one femur in each 323 
plate.  Bone marrow derived macrophages were passaged on day four by the following 324 
method:  medium was removed and retained, the adherent cells were incubated with 325 
Dulbecco’s Phosphate Buffered Saline (D-PBS; Life Technologies) for 5 minutes then 326 
detached from the plastic by washing vigorously with D-PBS using an 18 gauge needle and 327 
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syringe and recovered by centrifugation at 8000g.  Cells from each plate were then reseeded 328 
into two new plates in complete macrophage medium supplemented with 5ml original medium.  329 
On day 7, BMDM were harvested, counted and seeded into 100mm dishes, 96 well plates or 330 
onto 8 well glass chamber slides (BD Falcon) at 1x105 cells/ml.  BMDM were activated with 331 
either 1ng/ml IFN or 4ng/ml IL-4 (Peprotech) in complete macrophage media for 16 hours 332 
prior to infection with A/WSN/33.  Activating media was removed from activated BMDM and 333 
kept at 37°C while infection was carried out.  BMDM were infected at an MOI of 10 by 334 
incubation with virus diluted in serum free DMEM for 1 hour.  The inoculum was then removed 335 
and activating media replaced onto the cells to allow continued exposure to cytokine.  After 48 336 
hours, medium was removed for assay of iNOS and Arg-1 the cells were washed by incubation 337 
in Ca2+ Mg+ free PBS (Invitrogen) for 5 minutes, flushed from the dishes as described above, 338 
counted and pelleted by centrifugation at 1500g.  Cell pellets were stored at -80°C. 339 
 340 
Cell viability assays 341 
Activated and non-activated BMDMs in 96 well plates were infected at an MOI of 10 and, at 342 
appropriate time points, cell viability was measured using the CellTiter-Blue cell Viability Assay 343 
(Promega).  Samples were assayed in triplicate. 344 
 345 
Immunostaining 346 
Chamber slides were washed with PBS and fixed for 30mins with 4% (w/v) paraformaldehyde 347 
(PFA).  After fixation, slides were washed with PBS and either stained immediately or stored 348 
at 4°C until required.  Before staining, stored slides were washed with PBS and blocked for 349 
30mins at room temperature with CAS block (Invitrogen).  After extensive washing, slides were 350 
probed with 1 in 500 dilution of polyclonal goat anti–influenza A H1N1 strain USSR antibody 351 
(AbD Serotec) in CAS block.  After 30 minutes incubation at room temperature, slides were 352 
washed with PBS and bound antibody was detected by incubation for 30 minutes with rabbit 353 
anti-goat/sheep alexafluor-488 conjugated secondary antibody, diluted 1 in 1000 in CAS block 354 
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(Invitrogen).  Unbound conjugate was removed by washing with PBS and the slides were 355 
counterstained with DAPI and mounted in Prolong Gold (Life Techologies)  mounting medium.   356 
 357 
iNOS assays 358 
Active inducible nitric oxide synthase (iNOS) was determined by the Greiss reagent bioassay, 359 
which results in production of nitrite and a colour change from colourless to pink in the 360 
presence of enzyme.  100µL Greiss reagent, 5.8% (v/v) H3PO4, 1% (w/v) sulphanilamide, 361 
0.1% (w/v) N-(1-Naphthyl) ethylenediamine dihydrochloride was added to 100µL BMDM 362 
supernatant or 100µL sodium nitrite standard (Sigma) and absorbance read at 540nm.  363 
 364 
Arginase-1 bioassay 365 
Bioactive Arginase-1 was measured by conversion of L-Arginine to urea as follows.  1x105 366 
BMDM were plated onto 96 well flat bottomed plates (Nunc), washed with PBS and lysed with 367 
0.1% Triton-X (Sigma).  The lysate was then removed to sterile 1.5ml tubes.  After addition of 368 
100µL 25mM Tris-HCl and 20µL 10mM MnCl2, tubes were incubated at 56°C for 10 minutes.  369 
100µL of each sample was transferred to fresh tubes and incubated with 100µL 0.5M L-370 
Arginine for 2 hours.  During this time a standard dilution series of urea was made.  Following 371 
the incubation step, 800µL 10% (v/v) sulphuric/30% (v/v) phosphoric acid solution was added 372 
along with 40µL isonitropropiophenone, mixed by vortexing and incubated at 95°C for 30 373 
minutes.  Once cooled, samples and standards were placed in a 96 well plate and absorbance 374 
read at 540nm. 375 
 376 
Quantitative RT- PCR 377 
RNA was extracted from frozen BMDM using an RNeasy minikit and Qiashredders (Qiagen), 378 
as per manufacturer’s guidelines.  Genomic DNA was removed by treatment with DNA-free 379 
(Ambion) according to the manufacturer’s instructions.  1-2µg RNA was reverse transcribed to 380 
cDNA with Superscript III (Invitrogen).  cDNA was routinely diluted 1 in 20 for quantitative 381 
reverse transcriptase PCR (qRT-PCR) analysis.  Primers were designed as follows for each 382 
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gene of interest, along with reference genes succinate dehydrogenase A (SDHA) and calnexin 383 
(CNX).  SDHA and CNX were chosen from a panel of 12 housekeeping genes (Quantace) 384 
which were tested to determine the genes with the most stable expression in BMDMs.  Optimal 385 
amplification conditions were determined for each gene of interest to ensure >95% efficiency 386 
of single products.  qRT-PCR was carried out using a Rotorgene 3000 cycler (Qiagen). 387 
Primers sets are as follows: calnexin F ttagttgaccagtctgttg, R cctttcatcccaatcttcag;  succinate 388 
dehydrogenase A F gctcctactgatgaaacctg, R aactcaatcccttacagcaa;  iNOS F 389 
tgctactgagacagggaag, R gacagtctccattcccaa;  TNFα F caccaccatcaaggactcaa, R 390 
gacagaggcaacctgaccac;  IL-12p40 F ggaagcacggcagcagaata, R ttgagggagaagtaggaatgg;  M1 391 
F ctctctatcgtcccgtcagg, R gagcgtgaacac aaatccta. 392 
Each gene of interest was normalized to the reference genes using Genex software (MultiD) 393 
and relative expression of infected to mock controls was calculated.  394 
 395 
Statistical methods 396 
Statistical analysis of the differences in the various parameters of interest (the percentage of 397 
macrophages infected, normalised copy number, percentage survival and gene expression) 398 
following classical and alternative activation of macrophages in both 129Sv/Ev and IFNR-/- 399 
mice was performed using standard linear-mixed effect models (Pinheiro & Bates 2009),  400 
with individual mouse entered as the random effect to take account of the repeated measures 401 
taken from them. All statistical analyses were carried out on log10 transformed data to 402 
normalise the residuals and were performed in R (v 3.1.1 © 2014 The R Foundation for 403 
Statistical Computing), using the package ‘nlme’ (v 3.1-117).  Statistical significance was 404 
graded as * P<0.05, ** P<0.005, *** P<0.001. 405 
 406 
 407 
 408 
 409 
410 
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Figure legends 416 
Figure 1.  Influenza virus infection of 129Sv/Ev BMDMs.  BMDM cultured from femurs of 417 
female 129Sv/Ev mice were mock-infected or infected with A/WSN/33 and stained with 418 
antiserum to viral antigens (a) mock-infected cells; (b) 1h post-infection, MOI 10; (c) 6h post-419 
infection, MOI 10; (d) 48h post-infection, MOI 10.  420 
Figure 2.  Treatment of 129Sv/Ev bone marrow derived macrophages with IFN or IL-4 421 
leads to polarization of the macrophages to classical or alternative phenotypes. BMDMs 422 
derived from 129Sv/Ev and IFNR-/- mice were treated for 16h with 1ng/ml IFN or 4ng/ml IL-423 
4.  Expression of Arg-1 (a) or iNOS (c) mRNA was measured by qRT-PCR or by biochemical 424 
assay for Arg-1 activity (b) or iNOS activity (d).  425 
Figure 3.  Alternatively activated macrophages are more readily infected with A/WSN/33 426 
than classically activated macrophages.  BMDMs derived from 129Sv/Ev (a-e) and IFN R-427 
/- (f-j) mice were cultured in medium containing M-CSF alone (a,f) or treated with IFN (b,g) or 428 
IL-4 (c,h) for 16h and infected with 10pfu/cell A/WSN/33 followed by staining with antiserum to 429 
virus antigens.  The percentage of cells positive for antigen was quantitated at 6h (d,i) and 48h 430 
(e,j) * p<0.05 *** p<0.001.  431 
Figure 4.  Alternatively activated BMDMs produce more M1 mRNA than classically 432 
activated macrophages.  BMDMs were activated with IFN (classically activated) or IL-4 433 
(alternatively active) and infected with 10pfu/cell A/WSN/33.  48h post-infection, M1 mRNA 434 
levels were measured by qRT-PCR. *** indicates p<0.001.  435 
Figure 5.  Alternatively activated BMDMs are more susceptible to cell death following 436 
infection with A/WSN/33 but do not support higher levels of virus replication.  BMDMs 437 
from 129Sv/Ev and IFNR-/- mice were untreated or activated with IFN or IL-4 and infected 438 
with 10pfu/cell.  Cell viability was measured by the CellTiter-Blue assay at various times after 439 
infection.  (a) 129Sv/Ev BMDMs; (b) IFNR-/- BMDMs, *** p<0.001. Virus titres in cell 440 
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supernatants at 1h and 48h post-infection were measured by titration on MDCK cells (c). 441 
Results are representative of 3 independent experiments.  442 
Figure 6.  Expression of pro- and anti-inflammatory markers in classically and 443 
alternatively activated macrophages infected with influenza virus A/WSN/33.  BMDMs 444 
were treated with 1ng/ml IFN or 4ng/ml IL-4 for 16hours and then infected with 10pfu/cell 445 
A/WSN/33. Cells were harvested at 48 hours post-infection and expression of cellular 446 
markers was monitored by qRT-PCR. Results are representative of 3 independent 447 
experiments. (a,b) INOS; (c,d) Arg-1; (e,f) TNF; (g,h) CD206.   * p<0.05; ** p<0.005, 448 
***p<0.001. 449 
 450 
 451 
 452 
 453 
454 
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